Yumanity Therapeutics logo

Yumanity Therapeutics YMTX

$ 1.59 -8.91%

Quarterly report 2024-Q3
added 11-06-2024

report update icon

Country

usaUSA

IPO year

2016

Industry

-

Stock Exchange

NASDAQ CAPITAL

CEO

-

Employees in the company

-

Shares

11.1 M

Market Cap[1]

$ 17.2 M

EBITDA (LTM)

$ -15.9 M

P/E (LTM)

-

P/S (LTM)

-

EPS (LTM)

-

References

  1. Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.